Neridronic acid

奈立膦酸

Report date: 2025/12/24 13:38:31
NME

Base Information

Drug NameNeridronic acid
Drug Alias NameAminohexane diphosphonateacidum neridronicumNeridronateNeridronate SodiumNerixia +[8] 
ClassificationSmall molecules
Mechanisms of ActionBone resorption factor inhibitors
TargetsBone resorption factor
Therapy Area/IndicationsHypercalcemiaComplex Regional Pain SyndromesOsteitis Deformans +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGrünenthal GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrünenthal GmbH
Active IndicationsHypercalcemiaOsteitis DeformansOsteoporosis
Inactive IndicationsComplex Regional Pain Syndromes

Other Information

ATC CodeM05BA
Related LinksWikipedia